Deciphera Pharmaceuticals, (DCPH) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
1
Total Shares Held
50.00K
Total Value
$759.00K
Institutional Holding %
0.06%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Jun 30, 2024)
Institution | Shares | Ownership % | Value |
---|---|---|---|
DEKABANK DEUTSCHE GIROZENTRALE | 50.00K | 0.06% | $759.00K |
AMERICAN | - | 0.00% | $- |
JPMorgan CHASE | - | 0.00% | $- |
US BANCORP \DE\ | - | 0.00% | $- |
FRANKLIN RESOURCES | - | 0.00% | $- |
HUNTINGTON NATIONAL BANK | - | 0.00% | $- |
BANK OF AMERICA | - | 0.00% | $- |
WELLS FARGOMPANY | - | 0.00% | $- |
NORTHERN TRUST | - | 0.00% | $- |
PRICE T ROWE | - | 0.00% | $- |
Recent Insider Trading
Insider | Title | Transaction | Shares | Value | Date |
---|---|---|---|---|---|
Brightstar Associates Llc | 10 Percent Owner | X-InTheMoney | 48.14K | $481 | Apr 22, 2024 |
Brightstar Associates Llc | 10 Percent Owner | X-InTheMoney | 48.14K | $481 | Apr 22, 2024 |
Sherman Matthew L | Evp & Chief Medical Officer | A-Award | 17.27K | $- | Feb 15, 2024 |
Sherman Matthew L | Evp & Chief Medical Officer | S-Sale | 2.62K | $40.84K | Feb 16, 2024 |
Sherman Matthew L | Evp & Chief Medical Officer | A-Award | 69.10K | $1.10M | Feb 15, 2024 |
Kelly Thomas Patrick | Chief Financial Officer | A-Award | 17.27K | $- | Feb 15, 2024 |
Kelly Thomas Patrick | Chief Financial Officer | S-Sale | 3.01K | $47.01K | Feb 16, 2024 |
Kelly Thomas Patrick | Chief Financial Officer | A-Award | 69.10K | $1.10M | Feb 15, 2024 |
Pitman Jama | Svp, Chief Development Officer | A-Award | 10.00K | $- | Feb 15, 2024 |
Pitman Jama | Svp, Chief Development Officer | S-Sale | 2.27K | $35.41K | Feb 16, 2024 |
Recent Position Changes
Institution | Shares Changed | % Change | Date |
---|---|---|---|
VANGUARD | -4.57M | -100.00% | Aug 13, 2024 |
STATE STREET | -3.10M | -100.00% | Aug 14, 2024 |
GOLDMANCHS | -1.96M | -100.00% | Aug 13, 2024 |
DIMENSIONAL FUND | -1.61M | -100.00% | Aug 09, 2024 |
MORGAN STANLEY | -1.54M | -100.00% | Oct 17, 2024 |
JEFFERIES FINANCIAL | -822.51K | -100.00% | Aug 13, 2024 |
CHARLES SCHWAB | -531.48K | -100.00% | Aug 12, 2024 |
NORTHERN TRUST | -515.96K | -100.00% | Aug 14, 2024 |
DEUTSCHE BANK\ | -487.36K | -100.00% | Aug 14, 2024 |
JACOBS LEVY EQUITY | -471.98K | -100.00% | Aug 14, 2024 |
Recent Ownership Filings
SC 13G/A
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Jun 11, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Apr 24, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 20, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 20, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 20, 2024
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 20, 2024
Related Metrics
Explore detailed financial metrics and analysis for DCPH.